Literature DB >> 28245768

Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.

Sadaf Jahan1, Dipak Kumar2, Swati Chaturvedi1, Mamunur Rashid1, Muhammad Wahajuddin1, Yasir A Khan3, Sameer N Goyal4, C R Patil4, Rajesh Mohanraj5, Sandeep Subramanya6, Shreesh Ojha7.   

Abstract

Inflammasomes are multiprotein complexes having nucleotide-binding domain and leucine-rich repeat consisting members along with pyrin and HIN domain family. An inflammasome mainly consists of cytoplasmic sensor molecule, such as NLRP3, the adaptor apoptosisassociated speck-like protein containing caspase recruitment domain) protein along with effector procaspase-1. The inflammasome regulates caspase-1 activation, resulting in secretion of interleukin- 1β and interleukin-18. The inflammasome activation is linked with infection, stress, or other immunological signals involved in inflammation. The pathophysiological role of NLRP3 inflammasome in immune regulation, inflammatory receptor-ligand interactions, microbial-associated molecular patterns, danger as well as pathogen associated molecular patterns has been demonstrated in last few years. Furthermore, the role of the inflammasome in peripheral and central nervous system involved with cytokine and chemokine inflammatory responses has been demonstrated in preclinical and clinical studies. The understanding of molecular regulation of inflammasome associated pathways is crucial for drug design and delivery. The use of natural product as an alternate therapy is gaining focus because of easy access and cost effectiveness. A number of herbal extracts and its bioactive constituents known as phytochemicals have shown to be effective in inflammatory response mediated by NLRP3 inflammasomes pathways. To understand the interaction of phytochemicals and inflammasome at the molecular level, it is vital to develop effective drugs that can be evaluated further in the clinical settings. Therefore, this review renders an extensive account of all the phytochemicals which are evaluated either in inflammatory experimental animal models or in immortalized human/animal cell lines that modulate NLRP3 inflammasome mediated pathways to mitigate inflammatory responses with the hope that this pathway modulation by phytochemicals may provide a another class of drugs in the armamentarium as well as novel molecular mechanism of natural products targeting NLRP3 inflammasome. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Herbs; NLRP3; inflammasome; inflammation; inflammatory diseases; interleukins-1β; medicinal plants; phytochemicals

Mesh:

Substances:

Year:  2017        PMID: 28245768     DOI: 10.2174/0929867324666170227121619

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  NLRP3 Modulators for the Treatment of Autoinflammatory Disorders.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2018-09-19       Impact factor: 4.345

2.  Excretory/secretory proteins inhibit host immune responses by downregulating the TLR4/NF-κB/MAPKs signaling pathway: A possible mechanism of immune evasion in parasitic nematode Haemonchus contortus.

Authors:  Zhaohai Wen; Yue Zhang; Jiajun Feng; Kalibixiati Aimulajiang; Muhammad Tahir Aleem; Mingmin Lu; Lixin Xu; Xiaokai Song; Xiangrui Li; Ruofeng Yan
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

3.  MSC-ACE2 Ameliorates Streptococcus uberis-Induced Inflammatory Injury in Mammary Epithelial Cells by Upregulating the IL-10/STAT3/SOCS3 Pathway.

Authors:  Shuping Yan; Chonghao Zhang; Xiaoxia Ji; Gang Wu; Xinhe Huang; Yafeng Zhang; Yuanshu Zhang
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 4.  Dietary Supplements for COVID-19.

Authors:  Gerard E Mullin; Berkeley Limektkai; Lin Wang; Patrick Hanaway; Loren Marks; Edward Giovannucci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome.

Authors:  Maomao Zhang; Yang Zheng; Yong Sun; Shuang Li; Liangqi Chen; Xiangyuan Jin; Xinyu Hou; Xianglan Liu; Qi Chen; Jing Li; Mingyang Liu; Xianghui Zheng; Yongxiang Zhang; Jian Wu; Bo Yu
Journal:  Theranostics       Date:  2019-05-24       Impact factor: 11.556

Review 6.  Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.

Authors:  Carolina Pellegrini; Matteo Fornai; Luca Antonioli; Corrado Blandizzi; Vincenzo Calderone
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

Review 7.  Molecular Mechanisms of Anticancer Activities of Puerarin.

Authors:  Bashir Ahmad; Suliman Khan; Yang Liu; Mengzhou Xue; Ghulam Nabi; Sunjeet Kumar; Mohammed Alshwmi; Abdul Wakeel Qarluq
Journal:  Cancer Manag Res       Date:  2020-01-08       Impact factor: 3.989

Review 8.  Anti-NLRP3 Inflammasome Natural Compounds: An Update.

Authors:  Baolong Liu; Jiujiu Yu
Journal:  Biomedicines       Date:  2021-02-01

9.  A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction.

Authors:  Chun-Hsien Wu; Chin Heng Gan; Lan-Hui Li; Jen-Che Chang; Shin-Tai Chen; Mridula P Menon; Shu-Meng Cheng; Shih-Ping Yang; Chen-Lung Ho; Oleg V Chernikov; Chi-Hung Lin; Yulin Lam; Kuo-Feng Hua
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

10.  Synthetic 4-Hydroxy Auxarconjugatin B, a Novel Autophagy Inducer, Attenuates Gouty Inflammation by Inhibiting the NLRP3 Inflammasome.

Authors:  Chih-Yu Hsieh; Lan-Hui Li; Yulin Lam; Zhanxiong Fang; Chin Heng Gan; Yerra Koteswara Rao; Hsiao-Wen Chiu; Wei-Ting Wong; Tz-Chuen Ju; Fang-Hsin Chen; Oleg V Chernikov; May-Lan Liu; Chung-Hua Hsu; Kuo-Feng Hua
Journal:  Cells       Date:  2020-01-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.